Literature DB >> 27842789

Ketamine: A Cause of Urinary Tract Dysfunction.

Frank Anthony Myers1, Martin H Bluth2, Wellman W Cheung3.   

Abstract

Drug addiction as a result of improper use of prescribed and illicit use has been on the increase globally. The effects of such use have implications in the urologic disease space. To this end, Ketamine has been reported to affect urologic function, causing a number of voiding symptoms. It may also confound the differential diagnosis of urologic diseases, such as interstitial cystitis, among others.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder; Illicit; Inflammation; Ketamine; Urinary Tract Dysfunction; Urology

Mesh:

Substances:

Year:  2016        PMID: 27842789     DOI: 10.1016/j.cll.2016.07.008

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  6 in total

Review 1.  Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.

Authors:  Jason Ng; Leanna M W Lui; Joshua D Rosenblat; Kayla M Teopiz; Orly Lipsitz; Danielle S Cha; Jiaqi Xiong; Flora Nasri; Yena Lee; Kevin Kratiuk; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Roger Ho; Bing Cao; Roger S McIntyre
Journal:  Psychopharmacology (Berl)       Date:  2021-01-23       Impact factor: 4.530

Review 2.  How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.

Authors:  Raquel Santos-Toscano; Amira Guirguis; Colin Davidson
Journal:  Br J Clin Pharmacol       Date:  2020-02-23       Impact factor: 4.335

3.  Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug.

Authors:  Danyon J Anderson; Jessica Zhou; David Cao; Matthew McDonald; Maya Guenther; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-15

Review 4.  Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method.

Authors:  Ingrid Saba; Weronika Jakubowska; Stéphane Bolduc; Stéphane Chabaud
Journal:  Biomed Res Int       Date:  2018-03-08       Impact factor: 3.411

Review 5.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

Review 6.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.